Clinical Trial Update: Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (Late TIME Study) evaluating autologous stem cell therapy for left ventricular dysfunction after myocardial infarction has completed, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction
• Myocardial Infarction

Drugs mentioned

• Autologous stem cell therapy

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Left Ventricular Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2012-05-04